Increased tumor necrosis factor-α receptor number in chronic hepatitis B virus infection
- 1 July 1991
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 14 (1) , 44-50
- https://doi.org/10.1002/hep.1840140108
Abstract
Production of the antiviral cytokine, tumor necrosis factor-α is increased in chronic hepatitis B virus infection, and clinical studies of tumor necrosis factor-α have indicated a proviral effect at higher doses. To determine whether this might be related to abnormal cell surface tumor necrosis factor-α receptor expression, binding characteristics of cell surface tumor necrosis factor-α receptor on peripheral blood mononuclear cells in chronic hepatitis B virus carriers were studied using radioiodinated recombinant tumor necrosis factor-α. The specific binding curves generated were analyzed according to the method of Scatchard to determine cell surface receptor numbers and dissociation constants. A single class of cell surface tumor necrosis factor-α receptor was demonstrated on peripheral blood mononuclear cells and mononuclear subsets. The median number (range) of cell surface tumor necrosis factor-α receptors on peripheral blood mononuclear cells from controls (n = 11), chronic hepatitis B virus patients seropositive for hepatitis B virus DNA (n = 8) and seronegative for hepatitis B virus DNA (n = 8) were 2,329 (range = 1,538 to 3,133), 3,375 (range = 2,300 to 6,718) (p < 0.01) and 3,113 (range = 2,229 to 5,246) (p < 0.05) sites/cell, respectively. They all had similar dissociation constants of 8.4 × 10−10 mol/L (range = 4.1 to 16.9), respectively. Further dissection of the peripheral blood mononuclear cells showed that this increase in cell surface receptor number was confined to the monocyte fraction (p < 0.01). Plasma tumor necrosis factor-α levels in five patients with increased monocyte cell surface tumor necrosis factor-α receptor numbers were also elevated. No correlation between cell surface tumor necrosis factor-α receptor number and serum AST, HBsAg, hepatitis B virus DNA or liver histology was observed. These data indicate that cell surface tumor necrosis factor-α receptor number is increased in monocytes but normal in lymphocytes and support previous observations that monocytes are activated in chronic hepatitis B virus infection. (HEPATOLOGY 1991;14:44-50.)Keywords
This publication has 39 references indexed in Scilit:
- Increased production of tumour necrosis factor alpha in chronic hepatitis B virus infectionPublished by Elsevier ,1991
- Tumour necrosis factor to treat chronic hepatitis B virus infectionThe Lancet, 1990
- Spontaneous production of tumour necrosis factor α and interleukin-1β during interferon-α treatment of chronic HBV infectionThe Lancet, 1990
- Immunohistochemical studies of intrahepatic tumour necrosis factor alpha in chronic liver disease.Journal of Clinical Pathology, 1990
- Tumor Necrosis Factor α Production by Peripheral Blood Mononuclear Cells of Patients With Chronic Liver DiseaseHepatology, 1989
- Interferon alpha in hepatitis type B and non-A, non-BJournal of Hepatology, 1988
- Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.Gut, 1986
- Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult lifeHepatology, 1986
- Quantitation of hepatitis B virus dna (HBV DNA) in serum using the spot hybridization technique and scintillation countingJournal of Virological Methods, 1985
- Measurement of specific radioactivities in labelled hormones by self-displacement analysisBiochemical Journal, 1983